Is curcumin bioavailability a problem in humans: Lessons from clinical trials

AB Kunnumakkara, C Harsha, K Banik… - Expert opinion on …, 2019 - Taylor & Francis
Introduction: Since ancient times, turmeric has been used in several folklore remedies
against various ailments. The principal component of turmeric is curcumin and its efficacy …

Graphene quantum dots as a potential diagnostic and therapeutic tool for the management of Alzheimer's disease

S Ghosh, B Sachdeva, P Sachdeva, V Chaudhary… - Carbon Letters, 2022 - Springer
Alzheimer's disease (AD) is one of the most common forms of dementia, affecting more than
50 million people globally. The onset of AD is linked to age, smoking, obesity …

Neuroinflammation in Alzheimer's disease: the preventive and therapeutic potential of polyphenolic nutraceuticals

Y Sawikr, NS Yarla, I Peluso, MA Kamal, G Aliev… - Advances in protein …, 2017 - Elsevier
Brain inflammation, characterized by increased microglia and astrocyte activation, increases
during aging and is a key feature of neurodegenerative diseases, such as Alzheimer's …

[HTML][HTML] PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering Aβ generation inhibitor and curcumin attenuate memory deficits and …

N Huang, S Lu, XG Liu, J Zhu, YJ Wang, RT Liu - Oncotarget, 2017 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is the most common form of dementia, characterized by the
formation of extracellular senile plaques and neuronal loss caused by amyloid β (Aβ) …

Multifunctional nanocarriers for Alzheimer's disease: befriending the barriers

MA Ansari, T Tripathi, B Venkidasamy, A Monziani… - Molecular …, 2024 - Springer
Neurodegenerative diseases (NDDs) have been increasing in incidence in recent years and
are now widespread worldwide. Neuronal death is defined as the progressive loss of …

Rationalizing the use of polyphenol nano-formulations in the therapy of neurodegenerative diseases

N Kumari, N Daram, MS Alam… - CNS & Neurological …, 2022 - ingentaconnect.com
Neurodegenerative diseases are a heterogeneous group of disorders among aging
populations worldwide characterized by the progressive degeneration of the structure and …

Emerging novel approaches for the enhanced delivery of natural products for the management of neurodegenerative diseases

A Bandiwadekar, J Jose, M Khayatkashani… - Journal of Molecular …, 2022 - Springer
Neurodegenerative diseases (NDs) such as Alzheimer's disease, Parkinson's disease,
Huntington disease, amyotrophic lateral sclerosis, and prion disease affect any part of the …

Nanotized curcumin and miltefosine, a potential combination for treatment of experimental visceral leishmaniasis

B Tiwari, R Pahuja, P Kumar, SK Rath… - Antimicrobial Agents …, 2017 - Am Soc Microbiol
Leishmaniasis chemotherapy remains very challenging due to high cost of the drug and its
associated toxicity and drug resistance, which develops over a period of time. Combination …

Early blight disease management by herbal nanoemulsion in Solanum lycopersicum with bio-protective manner

S Pandey, VP Giri, A Tripathi, M Kumari… - Industrial crops and …, 2020 - Elsevier
Early blight, caused by Alternaria solani is one of the most devastating disease affecting to
the Solanum lycopersicum (tomato), reducing its productivity by 80%. The present study …

The impact of estradiol on neurogenesis and cognitive functions in Alzheimer's disease

S Sahab-Negah, V Hajali, HR Moradi… - Cellular and Molecular …, 2020 - Springer
Alzheimer's disease (AD) is described as cognitive and memory impairments with a sex-
related epidemiological profile, affecting two times more women than men. There is …